Stay updated on Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedThe site was updated from version v3.4.3 to v3.5.0. This release does not change the study content or user-facing information.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No other visible content changes were detected.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior government-funding notice (Revision: v3.4.1) from the page.SummaryDifference0.4%

- Check78 days agoChange DetectedAdded a government funding lapse notice affecting site status and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedGlossary display has been added and the 'Last Update Submitted that Met QC Criteria' field is now shown. The 'No FEAR Act Data' notice has updated capitalization and the page revision changed from v3.3.4 to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.